Cargando…

Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”

Detalles Bibliográficos
Autores principales:	Kumar Singh, Awadhesh, Singh, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305489/ https://www.ncbi.nlm.nih.gov/pubmed/32593934 http://dx.doi.org/10.1016/j.dsx.2020.06.005

Ejemplares similares

Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Letter in response to letter to the editor by Singh and Dhibar regarding the article “COVID-19: From bench to bedside” (Singh et al.)
por: Singh, Akriti, et al.
Publicado: (2020)

Reply to the letter of Singh and Singh in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis” (Kumar et al.)
por: Kumar, Ashish, et al.
Publicado: (2020)

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

A Letter to the Editor on the Article by Farnam et al
por: Rutte, Anne, et al.
Publicado: (2015)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to editor in response to article “COVID-19: From bench to bedside” (Singh et al.)
por: Singh, Harpreet, et al.
Publicado: (2020)

A Letter to the Editor on the Article by Farnam et al.−Author's Response
por: Farnaz, Farnam, et al.
Publicado: (2015)

Response from the Authors (Kumar P et al)[1]
Publicado: (2018)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Erratum for Kumar et al., “Indole Signaling at the Host-Microbiota-Pathogen Interface”
por: Kumar, Aman, et al.
Publicado: (2020)

Letter to the Editor in response to article: Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis (Martha et al.)
por: Siniorakis, Eftychios E., et al.
Publicado: (2021)

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Commentary on Pain Behaviors in Dementia: Letter to the Editor with Reference to the Article by Morrison et al. (2020)
por: Atee, Mustafa, et al.
Publicado: (2021)

An article on “letter to the editor”
por: Pandarathodiyil, Anitha K., et al.
Publicado: (2023)

Poems by Kumar
por: Kumar, Vinay
Publicado: (2008)

Letter to the editor in response to Komen et al. 2021
por: Kumar, Niraj S, et al.
Publicado: (2021)

Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447
por: Kumar, Abhinav, et al.
Publicado: (2022)

Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447
por: Kumar, Abhinav, et al.
Publicado: (2022)

Letter to the editor: in response to Alstrup et. al.
por: Slagt, Cor, et al.
Publicado: (2019)

Letter to the Editor response: Nygaard et al.
por: Towfic, F., et al.
Publicado: (2017)

Response to the Letter to the Editor by Eberhard et al.
por: Bottomley, Christian, et al.
Publicado: (2017)

Letter to the Editor in Response to Khazanchi et al.
por: Nayak, Aditi, et al.
Publicado: (2021)

Letter to the editor from Pant et al
por: Pant, Shubham, et al.
Publicado: (2021)

Letter to the Editor: In Response to Sarkar et al.
por: Pokhrel, Damodar, et al.
Publicado: (2021)

Reply to Letter to the Editor by Yin et al.
por: Coleman, Brenda L., et al.
Publicado: (2021)

Reply to the letter to the editor by Mungmunpuntipantip et al.
por: Longo, M., et al.
Publicado: (2021)

Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021)

Letter to the Editor from Colle et al
por: Colle, Raphael, et al.
Publicado: (2021)

Response to the Letter to the Editor by Mungmunpuntipantip et al
por: Stamenković, Marija, et al.
Publicado: (2022)

Letter to the Editor Reply: Kleebayoon et al.
por: Meador, Catherine B., et al.
Publicado: (2023)

Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)

Letter to the editor in response to article: “Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)
por: Gupta, Ritesh
Publicado: (2020)

Letter to the editor in response to article: “Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)
por: Hussain, Akhtar, et al.
Publicado: (2020)

Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)"
por: Home, Philip
Publicado: (2020)

Reply to the letter from Kumar et al.: Maastricht experience with the second-generation endoscopic laser balloon ablation system for the atrial fibrillation
por: Gal, P., et al.
Publicado: (2015)

Reply to letter to the editor on “A perspective on testing for gestational diabetes mellitus” by Seshiah V et al.
por: Mohan, Viswanathan, et al.
Publicado: (2015)

A Conversation with Ashok Kumar Singh
por: Chawla, Dalmeet Singh
Publicado: (2022)

Letter to the Editor re: Biglari et al. (2016)
por: Zura, Robert, et al.
Publicado: (2016)

Letter to the editor according to the study of Schwarze et al.
por: Sinnema, Marscha
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pri24csgo4qk5106m73k11qis9